Related Experiment Videos
Critical evaluation of prognostic factors
1Department of Breast Medical Oncology, M.D. Anderson Cancer Center, Houston, Texas, USA.
Seminars in Oncology
|August 1, 1996
Summary
Predicting breast tumor behavior using molecular factors offers improved risk assessment over traditional methods. This molecular approach aids in selecting optimal treatments and follow-up strategies for better patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Traditional breast cancer prognostication relies on tumor size, lymph node status, and histopathology.
- Molecular alterations in breast tumors are emerging as crucial prognostic factors.
- These molecular changes influence tumor malignancy characteristics like proliferation and metastasis.
Purpose of the Study:
- To explore the utility of molecular factors in predicting breast tumor behavior.
- To assess if molecular markers offer superior risk determination compared to conventional factors.
- To investigate the role of molecular alterations in guiding treatment decisions.
Main Methods:
- Review of preliminary data and recent studies on molecular prognostic factors in breast cancer.
- Analysis of genetic and biochemical alterations in tumor samples.
- Correlation of molecular markers with clinical outcomes and treatment response.
Main Results:
- Molecular factors may provide more accurate risk assessment for systemic relapse than conventional methods.
- HER-2/neu oncogene amplification/overexpression is linked to increased relapse risk after locoregional therapy.
- Molecular markers may also predict sensitivity to chemotherapy.
Conclusions:
- Understanding the molecular basis of breast cancer is key to personalized medicine.
- Molecular profiling can improve the identification of patients needing systemic therapy.
- This knowledge facilitates the selection of appropriate systemic therapy regimens.